Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
59,500
+100 (0.17%)
At close: Apr 30, 2026
Market Cap488.13B +43.2%
Revenue (ttm)16.48B +72.7%
Net Income-311.08M
EPS-38.00
Shares Out8.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume76,071
Average Volume79,004
Open60,500
Previous Close59,400
Day's Range58,100 - 60,900
52-Week Range38,300 - 101,000
Betan/a
RSI38.82
Earnings DateMar 27, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements